In Vitro Studies of BB-K8, a New Aminoglycoside Antibiotic
BB-K8, an aminoglycoside antibiotic which is a derivative of kanamycin, was tested in vitro against 466 clinical bacterial isolates. Over 90% of gram-negative bacilli, except Proteus spp., were inhibited by 3.12 μg of BB-K8 per ml. This antibiotic was consistently more active than kanamycin but less...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1973
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC444525/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/4790938/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.4.2.186 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|